Spatio-Temporal Alterations in Synaptic Density During Epileptogenesis in the Rat Brain
Jens D Mikkelsen1, Sanjay S Aripaka2, Pablo Bascuñana3
1Neurobiology Research Unit, University Hospital Copenhagen, Rigshospitalet, Copenhagen, Denmark; Department of Neuroscience, University of Copenhagen, Copenhagen, Denmark.
Neuroscience
|July 25, 2022
Summary
Synaptic vesicle glycoprotein 2A (SV2A) binding decreases in rat brains after induced epilepsy but returns to normal levels over time. This suggests synaptic changes in epilepsy are not permanent.
Area of Science:
- Neuroscience
- Epilepsy Research
- Synaptic Plasticity
Background:
- Synaptic vesicle glycoprotein 2A (SV2A) is crucial for neurotransmission and its levels are reduced in epilepsy.
- Previous studies show reduced SV2A in epilepsy models and human hippocampi, but effects on other brain regions and temporal dynamics are unclear.
Purpose of the Study:
- To investigate the temporal changes in SV2A binding capacity in various brain regions following induced status epilepticus (SE).
- To determine if SV2A reduction in epilepsy is permanent or reversible.
Main Methods:
- Generalized status epilepticus (SE) was induced in adult female rats using lithium-pilocarpine.
- Brain tissue was collected at different time points post-SE.
- Tritiated UCB-J binding was quantified using semiquantitative autoradiography in the cerebral cortex, hippocampus, thalamus, and hypothalamus.
Main Results:
- A significant reduction in SV2A binding was observed in the cerebral cortex and hippocampus within days after SE, but not in the thalamus or hypothalamus.
- The reduction was most pronounced and occurred earliest in the hippocampus and piriform cortex.
- SV2A binding capacity returned to control levels by 12 weeks post-SE in all examined areas.
Conclusions:
- Lithium-pilocarpine-induced epileptogenesis involves time-dependent changes in synaptic density, including both loss and gain.
- The observed reduction in SV2A binding is transient, suggesting a dynamic regulation of synapses during epileptogenesis and recovery.


